"While free samples clearly play a valuable role in helping millions of
financially-struggling patients get access to the medicines they need
to live healthier lives, patients should know there are other options,"
said Pharmaceutical Research and Manufacturers of America (PhRMA)
Senior Vice President Ken Johnson.
Among the "other options"
patients have to get access to the medicines they need are the over 200
Patient Assistance Programs (PAPs) sponsored by pharmaceutical and
biotech companies. Patient assistance programs are offered by
pharmaceutical companies to help low-income, under-insured, or
uninsured individuals and families afford necessary medications, with
reduced-cost or free prescription drugs.
Market Strategies' 2008 MSImage Oncology Patient Assistance Program is a syndicated study that identified what oncologists and oncology practice managers perceive to be the top pharmaceutical PAPs in the industry. The survey identified how PAPs influence
overall corporate image among physicians, what performance
measures drive a pharmaceutical company's PAP image, and which
companies are perceived as having the best PAP.
This article reviews this research with comments from Peter Carlin, Senior Vice President of Market Strategies.
Topic headings include:
Read this article now. It's FREE...
- Help Needed Today
- An Important Customer Touch Point
- MSImage Oncology Patient Assistance Program
- The Oncology Practice Manager Viewpoint
Download PDF file